All (%) | Age (%) | P-value | Odds ratio confidence interval 95% | Sex (%) | P-value | Odds ratio confidence interval 95% | Acute myocardial infarction (%) | P-value | Odds ratio confidence interval 95% | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
≤ 73 | > 73 | Women | Men | Yes | No | ||||||||
Complete vital signs registered | 1950 (93) | 970 (92) | 980 (94) | 0.031 | 1.04–2.07 | 988 (94) | 962 (93) | 0.336 | 0.60–1.19 | 231 (91) | 1719 (94) | 0.127 | 0.44–1.11 |
ECG registered | 2011 (96) | 1008 (96) | 1003 (97) | 0.241 | 0.84–2.05 | 1024 (97) | 987 (95) | 0.015 | 0.36–0.90 | 249 (98) | 1762 (96) | 0.101 | 0.86–5.36 |
Medical treatment | |||||||||||||
Oxygena | 54 (90) | 8 (89) | 46 (90) | 0.904 | 0.12–11.18 | 26 (93) | 28 (88) | 0.495 | 0.09–3.19 | 10 (77) | 44 (94) | 0.095 | 0.04–1.30 |
Acetylsalicylic acid | 587 (28) | 311 (39) | 276 (27) | 0.138 | 0.715–1.05 | 253 (24) | 334 (32) | < 0.001 | 1.24–1.82 | 127 (50) | 460 (25) | < 0.001 | 2.29–3.92 |
Sublingual glyceryl trinitrateb | 659 (53) | 354 (53) | 305 (54) | 0.708 | 0.83–1.31 | 323 (52) | 336 (55) | 0.355 | 0.89–1.39 | 95 (59) | 564 (53) | 0.105 | 0.94–1.85 |
Oxycodoneb | 484 (39) | 255 (38) | 229 (41) | 0.387 | 0.88–1.39 | 212 (34) | 272 (44) | < 0.001 | 1.22–1.93 | 87 (54) | 397 (37) | < 0.001 | 1.45–2.84 |
Ondansetronc | 177 (33) | 101 (31) | 76 (36) | 0.246 | 0.86–1.79 | 95 (31) | 82 (35) | 0.358 | 0.83–1.70 | 33 (52) | 144 (30) | 0.001 | 1.50–4.33 |